Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297996 · ClinicalTrials.gov registry record
Study of Gut Microbiome and Colorectal Tumors
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 540
- Enrollment target
NCT03297996 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 540 participants.
The verdict
NCT03297996 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 540 participants
- Enrollment target
Study Summary
Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon abundance among these groups.
Interventions
- DIAGNOSTIC_TEST Mobio PowerSoil DNA Isolation Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2011-11-23 |
| Est. Completion | 2015-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03297996
The ClinicalTrials.gov registry entry for NCT03297996 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobio PowerSoil DNA Isolation Kit is the first listed.
NCT03297996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03297996 about?
NCT03297996 is a clinical study titled "Study of Gut Microbiome and Colorectal Tumors". Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon abundance among these groups.
What is the current status of trial NCT03297996?
This trial is currently completed. The enrollment target is 540 participants. The study started on 2011-11-23. Estimated completion is 2015-04-25.
What interventions are being tested in trial NCT03297996?
The interventions under investigation include: Mobio PowerSoil DNA Isolation Kit (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03297996?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.